Voyager Therapeutics Inc Sustainability Reports
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. The company leverages its proprietary product engine and TRACER capsid discovery platform to discover and develop adeno-associated virus (AAV) gene therapies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930082S4XVR0ZWCC74
FIGI: BBG005ZSY242
3 reports from 2020 to 2023